OpenVSafe by OpenVAERS
Search V-safe

HLV-55949-68693

4 vaccinations 10 coded responses 28 check-ins 9 free-text entries 3 call cases
Sex
Female
Age at first dose
46-50
ZIP prefix
995 / AK
Registered
2021-02-27
Relationship
Self
Race
Multiracial
Ethnicity
Hispanic or Latino

Possible VAERS report

VAERS IDConfidenceScoreRunner-upShared symptomsDose StateVAERS vaccinated / onset / receivedCall case
2292858 (opens in a new window) high 8 / 11 — 0 of 2 VAERS symptoms same dose (4) AK matches 2022-04-18 / 2022-04-20 / 2022-05-24
received 7 days after the last call
case 695615

From the VAERS matching of call center cases (loader/vaers_match_*). Only the best match is shown, and only if it scores 8 or more out of 11. The score adds up timing (VAERS received soon after the call center contact), dose and shared symptoms; state only breaks ties. Confidence is high when the score is 8+ and at least 3 points ahead of the runner-up, medium when 5+ and 2 ahead, otherwise low. A match is a likely link, not a confirmed one.

Timeline

  1. 2021-02-06
    Dose 1 — Pfizer-BioNTech
  2. 2021-02-27
    Registered in v-safe
  3. 2021-02-27
    Dose 2 — Pfizer-BioNTech
  4. 2021-02-27
    Health check-in — day 0, dose 2
    Feeling: Good · Site: Itching · None
    Adult check-in
  5. 2021-02-28
    Survey response — days 1–6 daily, dose 2
    MedDRA: Rhinorrhoea — Feeling: Good · Site: Pain, Itching · Fatigue or tiredness
    Free text: Runny nose- may just be allergies
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2021-03-01
    Survey response — days 1–6 daily, dose 2
    MedDRA: Rhinorrhoea — Feeling: Fair · Site: Pain, Redness, Swelling, Itching
    Free text: Runny nose
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-03-02
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Fatigue or tiredness
    Adult check-in
  8. 2021-03-03
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · Fatigue or tiredness
    Adult check-in
  9. 2021-03-04
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  10. 2021-03-05
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  11. 2021-03-06
    Survey response — day 7, dose 2
    MedDRA: Rhinorrhoea, Sneezing — Feeling: Good · Site: Itching
    Free text: Runny nose and sneezing
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  12. 2021-03-13
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  13. 2021-03-20
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  14. 2021-03-29
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  15. 2021-04-03
    Survey response — day 35, dose 2
    MedDRA: Deafness — Feeling: Fair
    Free text: Loss of hearing
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  16. 2021-04-10
    Survey response — day 42, dose 2
    MedDRA: Deafness, Tinnitus — Feeling: Poor
    Free text: I cannot head out on one ear and ears are making a wierd dull noise.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  17. 2021-05-31
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  18. 2021-08-29
    Survey response — 6 months, dose 2
    MedDRA: Ageusia, Chills, Oropharyngeal pain — Feeling: Poor · Be unable to do your normal daily activities
    Free text: Sore throat, chills, loss of taste
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  19. 2021-10-19
    Dose 3 — Pfizer-BioNTech
  20. 2022-02-27
    Health check-in — 12 months, dose 2
    Feeling: Good
    Adult check-in
  21. 2022-04-18
    Dose 4 — Pfizer-BioNTech
  22. 2022-04-19
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · Site: Redness · None
    Adult check-in
  23. 2022-04-20
    Health check-in — days 1–6 daily, dose 4
    Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Headache, Fatigue or tiredness
    Adult check-in
  24. 2022-04-22
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · Site: Swelling, Itching · Fatigue or tiredness
    Adult check-in
  25. 2022-04-23
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · Site: Itching · Fatigue or tiredness
    Adult check-in
  26. 2022-04-24
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · Site: Itching · Headache
    Adult check-in
  27. 2022-04-25
    Health check-in — day 7, dose 4
    Feeling: Good · None
    Adult check-in
  28. 2022-05-02
    Health check-in — day 14, dose 4
    Feeling: Good
    Adult check-in
  29. 2022-05-09
    Health check-in — day 21, dose 4
    Feeling: Good
    Adult check-in
  30. 2022-05-16
    Survey response — day 28, dose 4
    MedDRA: Renal disorder — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Kidney issues
    MedDRA releases: 2024-11 · check-in free text available
  31. 2022-05-16
    Report sent to call center — day 28, dose 4
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  32. 2022-05-17
  33. 2022-05-23
    Survey response — day 35, dose 4
    MedDRA: Condition aggravated, Gastrooesophageal reflux disease, Pre-existing disease — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Kidney and Gerd- increased inflammation of auto immune disease in scalp, kidney, esophagus, bladder, lungs all throughout the body.
    MedDRA releases: 2024-11 · check-in free text available
  34. 2022-05-23
    Report sent to call center — day 35, dose 4
    Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  35. 2022-05-24
    Call successful
    Completed over the phone
  36. 2022-05-30
    Survey response — day 42, dose 4
    MedDRA: Condition aggravated, Pre-existing disease — Feeling: Good · Be unable to do your normal daily activities
    Free text: Autoimmune flare up
    MedDRA releases: 2024-11 · check-in free text available
  37. 2023-04-24
    Survey response — 12 months, dose 4
    MedDRA: COVID-19, Oropharyngeal pain, Thyroid disorder — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    MedDRA releases: 2024-11
  38. 2023-04-24
    Report sent to call center — 12 months, dose 4
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  39. 2023-04-25
    Call successful
    Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill

Vaccinations

DoseDateManufacturerCo-administered
12021-02-06Pfizer-BioNTech
22021-02-27Pfizer-BioNTech
32021-10-19Pfizer-BioNTech No
42022-04-18Pfizer-BioNTech No

Call center

3 call center cases

3 successful

VAERS report filed, before or during a call: 2

See the call center timeline

Free text

Release 4 — days 1–6 daily, dose 2

2021-02-28

Systemic reaction (other): Runny nose- may just be allergies

2021-03-01

Systemic reaction (other): Runny nose

Release 5 — day 7, dose 2

2021-03-06

Systemic reaction (other): Runny nose and sneezing

Release 6 — day 35, dose 2

2021-04-03

Symptoms: Loss of hearing

Release 7 — day 42, dose 2

2021-04-10

Symptoms: I cannot head out on one ear and ears are making a wierd dull noise.

Release 9 — 6 months, dose 2

2021-08-29

Symptoms: Sore throat, chills, loss of taste

Release 11 — day 28, dose 4

2022-05-16

Symptoms: Kidney issues

Release 11 — day 35, dose 4

2022-05-23

Symptoms: Kidney and Gerd- increased inflammation of auto immune disease in scalp, kidney, esophagus, bladder, lungs all throughout the body.

Release 11 — day 42, dose 4

2022-05-30

Symptoms: Autoimmune flare up

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAgeusia ✓ · ✓
SDChills ✓ · ✓
SDCondition aggravated · · ✓
SDCOVID-19 · · ✓
SDDeafness ✓ ✓ ✓
SDGastrooesophageal reflux disease · · ✓
SDOropharyngeal pain ✓ · ✓
SDPre-existing disease · · ✓
SDRenal disorder · · ✓
SDThyroid disorder · · ✓
SDTinnitus ✓ ✓ ✓
SRORhinorrhoea ✓ ✓ ✓
SROSneezing ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release